Stock Events

Stock Events

CTT Pharmaceutical 

$0.06
3
-$0-4.59% Today

Statistics

Day High
0.07
Day Low
0.07
52W High
0.1
52W Low
0.02
Volume
1,000
Avg. Volume
53,682
Mkt Cap
3.71M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31DecExpected
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-0.03
-0.02
-0.01
-0
Expected EPS
N/A
Actual EPS
-0.0039

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-500,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CTTH. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap148.9M
Corbus Pharmaceuticals develops cannabinoid-based drugs, directly competing with CTT in the therapeutic cannabinoid market.
Aurora Cannabis
ACB
Mkt Cap280.01M
Aurora Cannabis is engaged in the production and distribution of medical cannabis, indirectly competing with CTT by targeting the same medical conditions with different products.
Canopy Growth
CGC
Mkt Cap418.51M
Canopy Growth Corporation produces and sells medical cannabis, competing in the broader medical cannabis market that CTT also targets.
Tilray Brands
TLRY
Mkt Cap1.5B
Tilray engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids, which overlaps with CTT's market.
CV Sciences
CVSI
Mkt Cap5.53M
CV Sciences operates in the cannabinoid pharmaceutical industry, producing CBD pharmaceuticals that compete with CTT's offerings.

About

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.
Show more...
CEO
Ryan Khouri
Employees
2
Country
US
ISIN
US12651E1064

Listings

OTC Link
US
CTTH

0 Comments

Share your thoughts

FAQ

What is CTT Pharmaceutical stock price today?▼
The current price of CTTH is $0.06 USD — it has decreased by -4.59% in the past 24 hours. Watch CTT Pharmaceutical stock price performance more closely on the chart.
What is CTT Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CTT Pharmaceutical stocks are traded under the ticker CTTH.
Is CTT Pharmaceutical stock price growing?▼
CTTH stock has fallen by -10% compared to the previous week, the month change is a -13.7% fall, over the last year CTT Pharmaceutical has showed a +8.66% increase.
What is CTT Pharmaceutical market cap?▼
Today CTT Pharmaceutical has the market capitalization of 3.71M
What were CTT Pharmaceutical earnings last quarter?▼
CTTH earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is CTT Pharmaceutical revenue for the last year?▼
CTT Pharmaceutical revenue for the last year amounts to 0 USD.
What is CTT Pharmaceutical net income for the last year?▼
CTTH net income for the last year is -500,000 USD.
How many employees does CTT Pharmaceutical have?▼
As of April 01, 2026, the company has 2 employees.
In which sector is CTT Pharmaceutical located?▼
CTT Pharmaceutical operates in the Health Care sector.
When did CTT Pharmaceutical complete a stock split?▼
The last stock split for CTT Pharmaceutical was on August 28, 2015 with a ratio of 1:10.
Where is CTT Pharmaceutical headquartered?▼
CTT Pharmaceutical is headquartered in Ottawa, US.